The API/Sigma merger is currently before the ACCC for authorisation.This is a punt which could pay off for the speculative investor.Has anyone been watching this stock (i.e. API)?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025